Urology Surgical Instruments Market worth 11.48 Billion USD by 2021


Posted July 24, 2017 by dheerajshaha67

This market is expected to reach USD 11.48 Billion by 2021 from USD 7.74 Billion in 2016, at a CAGR of 8.2%.

 
The report "Urology Surgical Instruments Market by Product (Endoscopes, Endovision Systems, Peripheral Instruments, Consumables and Accessories), Application (Chronic Kidney Diseases, Benign Prostatic Hyperplasia, Oncology) - Global Forecast to 2021", This report studies the global urology surgical instruments market for the forecast period of 2016 to 2021. This market is expected to reach USD 11.48 Billion by 2021 from USD 7.74 Billion in 2016, at a CAGR of 8.2%.

Browse 132 market data Tables and 53 Figures spread through 201 Pages and in-depth TOC on "Urology Surgical Instruments Market”

http://www.marketsandmarkets.com/Market-Reports/urology-surgical-instrument-market-120080018.html

Early buyers will receive 10% customization on reports.

A number of factors such as rising prevalence of kidney diseases and urinary tract infections; rising number of hospitals and growing hospital investments in surgical infrastructure; availability of investments, funds, and grants from government bodies; and rising geriatric population are expected to drive the growth of the urology surgical instruments market during the forecast period.

In this report, the global urology surgical instruments market is segmented on the basis of product, application, and region. Based on product, the urology surgical instruments market is categorized into urology endoscopes, endovision systems, peripheral instruments, and consumables and accessories. The consumables and accessories segment is expected to account for the largest share of the urology surgical instruments market in 2016. The large share and high growth of this segment can be attributed to factors such as increasing surgical intervention for urology conditions, advancements in minimally invasive surgeries, increasing prevalence of chronic kidney disorders that can lead to increase in kidney transplants, increase in awareness of urology conditions at early stages, and rising geriatric population.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=120080018

Based on application, the urology surgical instruments market is segmented into chronic kidney disease (CKD), urinary stones, benign prostatic hyperplasia (BPH), urinary incontinence (UI) and pelvic organ prolapse (POP), oncology, and other applications (erectile dysfunction and hernia). The chronic kidney disease segment is expected to account for the largest share of the market in 2016; while, the urinary incontinence and pelvic organ prolapse segment is projected to grow at the highest CAGR in the forecast period. The high growth of this segment can be attributed to the increasing awareness of the condition and rising prevalence of urinary incontinence.

Geographically, the global urology surgical instruments market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, Middle East, and Africa). North America is expected to account for the largest share of the urology surgical instruments market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period (2016-2021).

Prominent players in the global urology surgical instruments market include Olympus Corporation (Japan), KARL STORZ GmbH & Co. KG (Germany), Richard WOLF GmbH (Germany), Coloplast A/S (Denmark), Cook Medical Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Teleflex incorporated (U.S.), Stryker Corporation (U.S.), CooperSurgical, Inc. (U.S.), and ConMed Corporation (U.S.).

Request Sample Report Pages: http://www.marketsandmarkets.com/requestsample.asp?id=120080018



About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
E-mail: [email protected]
Tel: 1-888-600-6441
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By D Shaha
Country India
Categories Biotech , Business
Tags urology surgical instruments market
Last Updated July 24, 2017